- Home
- PIII vs ENZ Comparison
PIII vs ENZ Comparison
Compare PIII & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- ENZ
- Stock Information
- Founded
- PIII 2015
- ENZ 1976
- Country
- PIII United States
- ENZ United States
- Employees
- PIII N/A
- ENZ N/A
- Industry
- PIII Medical/Nursing Services
- ENZ Medical Specialities
- Sector
- PIII Health Care
- ENZ Health Care
- Exchange
- PIII Nasdaq
- ENZ Nasdaq
- Market Cap
- PIII 37.5M
- ENZ 34.2M
- IPO Year
- PIII N/A
- ENZ N/A
- Fundamental
- Price
- PIII $0.23
- ENZ $0.55
- Analyst Decision
- PIII Buy
- ENZ
- Analyst Count
- PIII 3
- ENZ 0
- Target Price
- PIII $2.38
- ENZ N/A
- AVG Volume (30 Days)
- PIII 1.2M
- ENZ 167.5K
- Earning Date
- PIII 03-27-2025
- ENZ 03-12-2025
- Dividend Yield
- PIII N/A
- ENZ N/A
- EPS Growth
- PIII N/A
- ENZ N/A
- EPS
- PIII N/A
- ENZ N/A
- Revenue
- PIII $1,476,630,000.00
- ENZ $30,314,000.00
- Revenue This Year
- PIII $21.45
- ENZ N/A
- Revenue Next Year
- PIII N/A
- ENZ N/A
- P/E Ratio
- PIII N/A
- ENZ N/A
- Revenue Growth
- PIII 25.38
- ENZ N/A
- 52 Week Low
- PIII $0.17
- ENZ $0.41
- 52 Week High
- PIII $1.20
- ENZ $1.40
- Technical
- Relative Strength Index (RSI)
- PIII 60.20
- ENZ 36.19
- Support Level
- PIII $0.19
- ENZ $0.41
- Resistance Level
- PIII $0.25
- ENZ $0.69
- Average True Range (ATR)
- PIII 0.02
- ENZ 0.05
- MACD
- PIII 0.01
- ENZ 0.00
- Stochastic Oscillator
- PIII 75.64
- ENZ 54.04
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.